Holen Sie sich die Stockscreener-App
0.3124
1.36%
-0.0043
Handel nachbörslich:
.31
-0.0024
-0.77%
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
Historical volatility pattern of Co Diagnostics Inc. visualized2025 Short Interest & Community Trade Idea Sharing - Newser
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 29.3% in July - Defense World
News impact scoring models applied to Co Diagnostics Inc.Swing Trade & Fast Gain Stock Tips - Newser
Will breakout in Co Diagnostics Inc. lead to full recovery2025 Growth vs Value & Reliable Breakout Forecasts - Newser
How to build a custom watchlist for Co Diagnostics Inc.Market Trend Summary & Reliable Volume Spike Trade Alerts - Newser
Using flow based indicators on Co Diagnostics Inc.Fed Meeting & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-08-19 16:25:23 - Newser
Multi asset correlation models including Co Diagnostics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - Newser
Co-Diagnostics stock rating reiterated as Neutral by H.C. Wainwright - Investing.com
Co-Diagnostics Sales Plunge 93 Percent - AOL.com
Co-Diagnostics to Showcase Logix Smart and Co-Dx PCR at Next Generation Dx Summit in D.C. - AInvest
When is the best time to buy Co Diagnostics Inc. stockShort Setup & Capital Efficient Trade Techniques - Newser
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C. - BioSpace
Co-Diagnostics To Showcase Advancements At Seventeenth Next Generation Dx Summit In Washington, D.C., US: A Step Towards Enhanced Diagnostics For Medical Tourists - Travel And Tour World
Leading Molecular Diagnostics Firm Co-Diagnostics Unveils Next-Gen PCR Platform at Major Summit - Stock Titan
Co-Diagnostics Q2 2025 net loss hits USD 7.7 million - Medical Buyer
Co-Diagnostics Q2 Earnings Miss: Market Impact and Outlook Amid Weak Performance - AInvest
Reviewing Bausch + Lomb (NYSE:BLCO) & Co-Diagnostics (NASDAQ:CODX) - Defense World
What indicators show strength in Co Diagnostics Inc.2025 Support & Resistance & Capital Protection Trading Alerts - Newser
Trend analysis for Co Diagnostics Inc. this weekJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Co-Diagnostics Q2 Earnings Miss: Market Impact and Recovery Signals - AInvest
Co-Diagnostics (NASDAQ:CODX) Earns “Buy” Rating from D. Boral Capital - Defense World
Co Diagnostics Inc. stock daily chart insightsTrade Entry Report & Reliable Price Action Trade Plans - Newser
Using data tools to time your Co Diagnostics Inc. exit2025 Historical Comparison & Momentum Based Trading Signals - Newser
D. Boral Capital Reaffirms Buy Rating for Co-Diagnostics Stock with $10.00 Price Target - AInvest
Co-Diagnostics Inc Reports Q2 2025 Earnings: EPS Loss of $0.23 Beats Estimates, Revenue at $0.2 Million Surpasses Expectations. - AInvest
Co-Diagnostics: A Pre-Revenue Biotech with a Clear Path to Commercialization and Strong Balance Sheet - AInvest
Co-Diagnostics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2025 Earnings Call Transcript - Insider Monkey
Is Now a Good Time to Reenter Co Diagnostics Inc.2025 Stock Rankings & Reliable Entry Point Alerts - 선데이타임즈
How to escape a deep drawdown in Co Diagnostics Inc.Market Risk Report & Fast Moving Stock Watchlists - Newser
RSI and MACD Indicate Shift in Co Diagnostics Inc. SentimentPortfolio Gains Report & Community Shared Stock Ideas - 선데이타임즈
Will Co Diagnostics Inc. stock go up soonWeekly Investment Recap & Smart Money Movement Tracker - Newser
Camp4 Reports Q2 Revenue Beats Estimates - AOL.com
CODX.O: Sharp Intraday Surge Without Clear Fundamental Catalyst - AInvest
Co-Diagnostics (CODX) Surges 15.7% on Unusual Intraday Volatility—What’s Fueling the Surge? - AInvest
Co-Diagnostics, Inc. shares rise 16.23% intraday after Q2 2025 earnings call. - AInvest
When is the best time to exit Co Diagnostics Inc.Entry Point & Free AI Powered Buy and Sell Recommendations - Newser
CODX.O Surges 37.5%—But No Fundamental News—Technical Clues and Order-Flow Hints Point to Institutional Involvement - AInvest
Co-Diagnostics Soars 27% on Earnings Optimism and Regulatory Momentum - AInvest
Co-Diagnostics Inc Reports Q2 2025 Earnings: EPS Loss of $0.23 Beats Estimates, Revenue at $0.2 Million Surpasses Expectations - GuruFocus
Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform - MSN
Understanding Co Diagnostics Inc.’s price movementWeekly Profit Report & AI Powered Buy/Sell Recommendations - Newser
Co-Diagnostics: Boral Capital Raises PT to $10, Maintains Buy Rating - AInvest
Ranking Co Diagnostics Inc. among high performing stocks via toolsTrade Risk Summary & Community Shared Stock Ideas - Newser
Co-Diagnostics Inc (CODX) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results - BioSpace
bioAffinity Misses Q2 Revenue Target - AOL.com
Co-Diagnostics Reports Q2 2025 Financial Results - TipRanks
Co-Diagnostics Q2 rev down 92.6% to $0.2mln, op expenses down 19.1% YoY. - AInvest
Co-Diagnostics Progresses PCR Platform Clinical Trials, Targets Mid-2026 Commercialization. - AInvest
Co-Diagnostics (CODX): A High-Risk, High-Reward Play on the Future of Affordable Point-of-Care PCR Testing - AInvest
Earnings call transcript: Co-Diagnostics beats Q2 2025 EPS expectations By Investing.com - Investing.com Nigeria
Trendline Breach Raises Concern for Co Diagnostics Inc. InvestorsJuly 2025 Big Picture & Community Verified Trade Alerts - beatles.ru
Co-Diagnostics CODX Earnings Call Transcript - AOL.com
Earnings call transcript: Co-Diagnostics beats Q2 2025 EPS expectations - Investing.com
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Co-Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Co-Diagnostics Q2 2025 Earnings: GAAP EPS Loss $0.23, Revenue Down 92.6% to $0.2 Million - AInvest
Co-Diagnostics earnings beat by $0.43, revenue was in line with estimates - Investing.com Canada
Co-Diagnostics Sales Plunge 93 Percent - The Motley Fool
How Co Diagnostics Inc. stock performs during market volatilityMarket Activity Recap & Precise Swing Trade Entry Alerts - Newser
0.86%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):